CNBC.com News Now: Roubini on the Economy

Click here to view today's top stories on your mobile device. Monday, Oct. 26, 2009     DOW 9867.96 -104.22 -1.05%   NASDAQ 2141.85 -12.62 -0.59%   S&P 1066.95 -12.65 -1.17%     NEWS MARKETS EARNINGS INVESTING VIDEO CNBC TV SIGN IN     WHAT YOU SHOULD KNOW Too-Big-To-Fail Plan Will Not Include Industry Fund The Obama administration and House Democrats are no longer considering having financial firms pre-pay into a fund to help cover the costs of government intervention in winding down the businesses of too-big-too-fail financial firms, according to an one industry executive... »read more Senate Health-Care Bill to Include Public Option: Reid U.S. Senate Democratic leader Harry Reid said Monday the Senate's sweeping healthcare reform bill would include a government-run insurance plan that lets states opt out of participation if they choose... »read more Carbon Trading Market? Build It And They Will Invest Ahead-of-the-curve retail investors looking to play carbon as a commodity may want to bone up on the facts while they are waiting for the nascent market to scale up... »read more CNBC's Earnings Central On-air - Online - On Mobile Stay with CNBC for Real-Time Earnings reports and analysis. This week, reports from Arrow Electronics, Coca-Cola, Exxon Mobil, Chevron, Proctor & Gamble and more. »earningscentral.cnbc.com TODAY'S TOP 5 VIDEOS 1. Roubini on the Economy  Nouriel Roubini, chairman of RGEMonitor.com, shares his outlook on the economy. 2. Reid: Senate's Health Care Bill  Senate Majority Leader Harry Reid (D-NV) discusses the merger of the Senate's different health care bills, including a public option that allows states to opt out. 3. Forstmann Talks Wall Street's Future  Buyout king and Wall Street legend Teddy Forstmann discusses the future of Wall Street with CNBC's Charlie Gasparino. 4. $110 Oil Coming?  Daniel Dicker, an independent oil trader, shares his outlook on oil prices. 5. Stop Trading, Listen to Cramer!  Mad Money host Jim Cramer shares his stock picks with CNBC's Erin Burnett.       TODAY'S TOP BLOG   Vivus' Mr. Wilson Goes To Washington Patients on Vivus' [VVUS 9.81 0.63 (+6.86%) ] late-stage developmental diet drug, Qnexa, lost an average 37 pounds in 13 months. Now, CEO Leland Wilson is carrying that load up to Capitol Hill. »See All CNBC.com Blogs

FOLLOW CNBC   Become a fan on Facebook   Follow us on Twitter Advertise With Us | Visit Our Member Center to Unsubscribe and Manage Your Notification Settings FIRST IN BUSINESS WORLDWIDE. © 2009 CNBC Inc. All Rights Reserved 900 Sylvan Ave Englewood Cliffs, NJ 07632

Please note that cnbconline@cnbc.com is an unmonitored mailbox. To unsubscribe click here.